The present invention provides breast cancer markers based on RECQL mutations,and relatedmethods, uses, agents, and kits. The invention includes methods fordetermining thesusceptibility of a subject to developing breast cancer, and methods fordetecting, diagnosing,treating, and predicting responses to treatment for breast cancer.